Holen Sie sich die Stockscreener-App
71.82
2.40%
1.68
Vorhandelsmarkt:
72.12
0.30
+0.42%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CVS?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$70.14
Offen:
$70.4
24-Stunden-Volumen:
7.72M
Relative Volume:
0.92
Marktkapitalisierung:
$91.37B
Einnahmen:
$402.11B
Nettoeinkommen (Verlust:
$1.73B
KGV:
51.91
EPS:
1.3835
Netto-Cashflow:
$7.81B
1W Leistung:
-1.35%
1M Leistung:
-10.11%
6M Leistung:
-4.74%
1J Leistung:
+6.01%
1-Tages-Spanne:
$70.25
$72.20
1-Wochen-Bereich:
$69.51
$73.38
52-Wochen-Spanne:
$58.35
$85.15
Cvs Health Corp Stock (CVS) Company Profile
Firmenname
Cvs Health Corp
Sektor
Branche
Telefon
(401) 765-1500
Adresse
ONE CVS DR., WOONSOCKET
Compare CVS vs UNH, CI, ELV, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
71.82 | 89.23B | 402.11B | 1.73B | 7.81B | 1.3835 |
UNH
Unitedhealth Group Inc
|
270.59 | 237.62B | 447.57B | 12.81B | 16.08B | 13.19 |
CI
Cigna Group
|
266.75 | 68.05B | 274.88B | 6.29B | 8.39B | 22.19 |
ELV
Elevance Health Inc
|
292.75 | 62.56B | 199.13B | 5.66B | 3.17B | 25.11 |
HUM
Humana Inc
|
173.39 | 19.93B | 129.66B | 1.20B | 375.00M | 9.8083 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-12 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-10-14 | Eingeleitet | Goldman | Buy |
| 2025-08-18 | Hochstufung | UBS | Neutral → Buy |
| 2025-08-14 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | Hochstufung | Edward Jones | Hold → Buy |
| 2024-12-03 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-05-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-05-02 | Herabstufung | UBS | Buy → Neutral |
| 2024-05-01 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-22 | Eingeleitet | HSBC Securities | Buy |
| 2023-09-19 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Herabstufung | Edward Jones | Buy → Hold |
| 2023-05-26 | Eingeleitet | Piper Sandler | Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Eingeleitet | Goldman | Buy |
| 2021-12-01 | Eingeleitet | Seaport Research Partners | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-03-17 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-01-08 | Hochstufung | Jefferies | Hold → Buy |
| 2020-09-17 | Eingeleitet | Piper Sandler | Overweight |
| 2020-07-01 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-05-14 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-06-05 | Hochstufung | Standpoint Research | Hold → Buy |
| 2019-04-29 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Eingeleitet | Guggenheim | Buy |
| 2019-04-15 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Bestätigt | BofA/Merrill | Buy |
| 2019-03-13 | Eingeleitet | Bernstein | Outperform |
| 2019-02-20 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2018-12-18 | Eingeleitet | Barclays | Overweight |
| 2018-11-29 | Fortgesetzt | Goldman | Neutral |
| 2018-11-28 | Eingeleitet | Evercore ISI | Outperform |
| 2018-10-26 | Fortgesetzt | Wolfe Research | Peer Perform |
| 2018-07-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-02-13 | Bestätigt | Citigroup | Neutral |
Alle ansehen
Cvs Health Corp Aktie (CVS) Neueste Nachrichten
CVS Health Corp Stock Operating Data - GuruFocus
CVS Health Corp. stock rises Tuesday, still underperforms market - MarketWatch
CVS Specialty delivers personalized care through 30+ Centers of Excellence - CVS Health
CVS To Increase Retail Footprint After 4 Years Of Shrinking Its Store Count - Bisnow
Nation's largest pharmacy chain set to open 60 new locations just months after retail apocalypse - The US Sun
Piper Sandler Issues Pessimistic Forecast for CVS Health (NYSE:CVS) Stock Price - MarketBeat
Piper Sandler Adjusts Price Target for CVS Health (CVS) to $99 | - GuruFocus
CVS plans 20 pharmacy-only stores in shift toward expansion - Supermarket News
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields - Benzinga
Retirement Systems of Alabama Acquires 606,054 Shares of CVS Health Corporation $CVS - MarketBeat
Spire Wealth Management Has $2.09 Million Position in CVS Health Corporation $CVS - MarketBeat
apricus wealth LLC Lowers Position in CVS Health Corporation $CVS - MarketBeat
CVS Health Expands with New Pharmacy-Only Locations - GuruFocus
CVS launches new ‘pharmacy-only’ store – and 19 more are in the pipeline - The US Sun
CVS Health (CVS) Reaches Proposed FTC Settlement on Insulin Pricing - Insider Monkey
CVS Health opens first of 5 pharmacy-only stores planned for Chicago - The Business Journals
CVS to Open Pharmacy-Only Location in Chicago’s West End - Progressive Grocer
CVS Pharmacy® celebrates opening of first pharmacy-only location in Chicago - CVS Health
CVS starts smaller neighborhood pharmacies, plans nearly 20 in 2026 - Stock Titan
Roundup: Sysco’s $29B deal / Alliance for Affordable Energy / CVS pharmacies - Baton Rouge Business Report
CVS to Open More Stores in 2026 Than It Shuts in Retail Turnaround - Bloomberg.com
Canoe Financial LP Buys 194,555 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Stock Quote Price and Forecast - CNN
Wedge Capital Management L L P NC Has $27.60 Million Stock Holdings in CVS Health Corporation $CVS - MarketBeat
Wincap Financial LLC Lowers Stock Holdings in CVS Health Corporation $CVS - MarketBeat
CVS Health Corp. stock outperforms competitors despite losses on the day - MarketWatch
SEC filing of the week: Retired health executive joins CVS board - Providence Business News
Fort Washington Investment Advisors Inc. OH Boosts Holdings in CVS Health Corporation $CVS - MarketBeat
CVS Technical Analysis | Trend, Signals & Chart Patterns | CVS HEALTH CORP (NYSE:CVS) - ChartMill
Sonoma Pharmaceuticals (SNOA) Jumps 16% After Hours On Burn Relief Hydrogel Launch In Walmart, CVS - Benzinga
Vanguard disaggregates holdings; reports 0% in CVS (NYSE: CVS) - Stock Titan
NATPAT Launches Into CVS Nationwide in Brand's Largest U.S. Retail Expansion - GlobeNewswire Inc.
Mark Cuban Calls $30,000 Corporate Healthcare Burden 'Insane,' Backs Bill To Break Up Big Medicine Giants UNH, CVS, CI - Yahoo Finance
Judge dismisses lawsuit by Musk's X Corp accusing advertisers of illegal boycott - Reuters
Improving health one In-Home Health Evaluation at a time - CVS Health
Peak Financial Advisors LLC Acquires 19,298 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Health Corp (XSWX:CVS) Stock News, Headlines & Updates - GuruFocus
CVS Health Corp. stock slides amid broader market pressures as healthcare sector faces headwinds - AD HOC NEWS
CVS HEALTH Corp's iShares Broad USD High Yield Corporate Bond ETF(USHY) Holding History - GuruFocus
CVS Health Corp. stock slides 1.1% to 72.02 USD on NYSE amid broader S&P 500 pressure - AD HOC NEWS
CVS Caremark nears settlement with FTC as federal regulators target insulin pricing practices - The Business Journals
UBS reiterates CVS Health stock Buy rating after FTC settlement - Investing.com
SG Americas Securities LLC Acquires 1,015,775 Shares of CVS Health Corporation $CVS - MarketBeat
Provider-insurer contract disputes surge amid denials, downcoding - Modern Healthcare
CVS.DE Stock Price, Quote & Chart | CVS HEALTH CORP (FRA:CVS) - ChartMill
CVS Health (CVS) Strengthens Market Position Amid Analyst Confidence and Industry Shifts - Insider Monkey
Headquarters of CVS Health Corp in Woonsocket - reutersconnect.com
Research Alert: CFRA Maintains Hold Rating On Shares Of Cvs Health Corp. - moomoo.com
CVS Health (CVS) Ascends While Market Falls: Some Facts to Note - Yahoo! Finance Canada
CVS Reaches Proposed Settlement with FTC, Easing Uncertainty - GuruFocus
FTC strikes proposed deal with CVS over charges its PBM manipulated insulin prices, impeded access - statnews.com
Finanzdaten der Cvs Health Corp-Aktie (CVS)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):